Showing results (131-140 of 322) with videos related to

Sort By:
Pageof 33
Acta Dermato-Venereologica|March 16, 2016
Relative Frequency, Clinical Features, and Survival Outcomes of 395 Patients with Cutaneous Lymphoma in Korea: A Subgroup Analysis per 10-year PeriodWoo Jin Lee, Sang Hyung Lee, Ik Jun Moon, et al.
Blood Research|January 16, 2018
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphomaEun-Ji Choi, Jung Yong Hong, Dok Hyun Yoon, et al.
Cancer Chemotherapy and Pharmacology|October 8, 2008
A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphomaSun Jin Sym, Dae Ho Lee, Hye Jin Kang, et al.
Leukemia & Lymphoma|November 1, 2011
Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphomaDeok-Hwan Yang, Won Seog Kim, Seok Jin Kim, et al.
Journal of Clinical Apheresis|April 27, 2012
Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myelomaJae-Cheol Jo, Dok Hyun Yoon, Shin Kim, et al.
Annals of Hematology|September 29, 2020
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)Sora Kang, Hyungwoo Cho, Byeong Seok Sohn, et al.
The Korean Journal of Internal Medicine|September 11, 2010
Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphomaChanghoon Yoo, Shin Kim, Byeong Seok Sohn, et al.
Annals of Hematology|January 27, 2007
High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survivalMin Kyoung Kim, Shin Kim, Sung Sook Lee, et al.
Annals of Hematology|August 22, 2007
BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicityJae-Cheol Jo, Byung Wook Kang, Geundoo Jang, et al.
Hematological Oncology|October 27, 2016
Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexateYun Jung Choi, Hyangmin Park, Ji Sung Lee, et al.
Pageof 33